Abstract
Previously, we determined that genetic and environmental factors contributed equally towards rosacea in twins. To assess an environmental factor, we characterized the malar cheek bacterial microbiome from twins discordant for rosacea. We found no significant difference in facial microbiome alpha and beta diversity between related twins discordant for rosacea. However, the relative percentage abundance of Gordonia and Geobacillus, low-abundant genera, was positively and negatively associated with rosacea severity, respectively. Our data demonstrate a significant correlation between facial microbiome and severity of rosacea in genetically matched twins and importantly that overall microbiome composition is largely unchanged.
Keywords: 16S rRNA, alpha and beta diversity, microbiome, NRS score, relative percentage abundance
1 |. BACKGROUND
Rosacea is a chronic inflammatory disease of the facial skin and eyes that affects ~16 million individuals in the United States alone. Although its aetiology is unknown, we previously determined that both genetic and environmental factors contribute equally towards disease using identical (monozygotic) and fraternal (dizygotic) twins.[1] Previous studies have implicated microbial colonization and the cognate immune response as the critical driver of rosacea.[2,3] Increased levels of Demodex mites and associated bacteria (bacillus), antimicrobial peptides (eg cathelicidin/LL37), host immune variables (eg Toll-like receptor (TLR)-2) and nutrients (eg vitamin D3) are reported to alter the innate immune response and cause chronic inflammation and the facial skin sensitivity in rosacea.[2,3] In addition, the recent studies suggest significant associations between the severity of rosacea and systemic comorbidities (eg cardiovascular, allergic, respiratory, metabolic and gastrointestinal diseases) that are linked with chronic inflammation.[4,5] Rosacea and its reported comorbidities share involvement with barrier tissues that are colonized with a wide variety of micro-flora that constitute the microbiome.
2 |. QUESTION ADDRESSED
The beneficial use of therapeutic drugs for rosacea including oral and topical antibiotics, sulphur compounds and ivermectin that alter the facial microbiome,[6] suggests that altering the resident skin microbiome may play a role in the disease. However, no conclusive evidence has been established.
Microbial dysbiosis could be one of the factors associated with the pathogenesis of rosacea as well as its comorbidities. Harnessing the genetic and environmental control inherent in a twin study, we performed next-generation sequencing of the 16S rRNA gene to evaluate the hypothesis that facial bacterial microbiome dysbiosis will associate with the severity of rosacea in twins discordant for rosacea.
3 |. EXPERIMENTAL DESIGN
See Appendix S1.
4 |. RESULTS
4.1 |. Comparable overall facial skin microbiome composition across subjects
We estimated the relative percentage abundance (RPA) of facial bacterial microbiome at the phylum level in twins with and without rosacea. The top four abundant phyla were Firmicutes (mean ± SD; 42.98% ± 1.05%), Proteobacteria (39.29% ± 1.11%), Actinobacteria (15.88% ± 0.78%) and Bacteroidetes (1.04% ± 1.85%) in all subjects (Figure 1A and Table S1), and our data were generally consistent with the previous reports of other facial skin sites.[7,8] We found that Firmicutes were present in greater abundance than Actinobacteria. However, Proteobacteria were represented by a greater number of genera than Firmicutes and Actinobacteria (Table S1). There was no significant difference in mean abundance for all phyla when compared between different sites (left versus right cheek) or disease (no rosacea versus rosacea) groups. Thus, both inter- and intrapersonal variability in mean abundance of microbiome was observed. The principal coordinates analysis confirmed both inter- and intrapersonal variability and revealed no distinct difference between individuals with and without rosacea (Figure 1B).
4.2 |. Comparable alpha and beta diversity of twin pairs discordant for rosacea
The assessment of facial bacterial microbiome alpha diversity (S1) by Shannon index showed comparable alpha diversity between monozygotic twin pairs with and without rosacea (Figure S1A).
There are earlier reports[9] of skin diseases that showed less bacterial diversity in disease states. Given the paired nature of data, we plotted the National Rosacea Society (NRS) scores differences versus alpha diversity differences between related twin pairs (Figure S1B). We found a negative association between NRS score differences and alpha diversity differences. These data suggest that rosacea negatively impacting bacterial diversity. The non-significance might be due to a low number of samples at high NRS score.
Next, we determined whether facial microbiome beta diversity (S1) is distinct between subjects with rosacea and healthy subjects. Principal component analysis for unweighted, weighted UniFrac (WUF) or Bray-Curtis beta diversity measures (S2) showed no distinct segregation between healthy versus rosacea subjects (data not shown). However, we found that WUF distance between siblings in which only one individual has rosacea was greater than WUF distance between siblings with rosacea and WUF distance between siblings without rosacea (Figure S2). These data indicate the trend that the facial microbiome is more diverse between siblings if rosacea is present, although it did not meet the statistical significance.
Consistent with a previous study,[8] we also found that the related monozygotic twins have more similar (lowest mean WUF distance) facial bacterial microbiome than related dizygotic twins and significantly dissimilar than unrelated twins (Figure S3).
4.3 |. Facial skin bacterial microbiome correlates with NRS score
We tested the hypothesis that the changes in the facial microbial community might be associated with rosacea severity. We found a significant (p < .05) correlation between NRS score and the RPA of 9 genera (Table S3).
To evaluate the association between NRS score and RPA of bacterial genera and demographics, we performed random effect Poisson regression (REPR) analysis (see Section 3 Experimental Design for rationale and details). Univariate REPR analysis revealed a significant (P < .05) association between NRS scores and six genera: Gordonia, Blautia, Chryseobacterium, Wautersiella, Geobacillus and unknown genus (phylum Proteobacteria) but not with demographics listed in Table S1. Multivariate REPR analyses found that only two genera (Gordonia and Geobacillus), age group 30–60 years versus 0–30 years, and birth order B versus A remained significantly predictive of NRS score. REPR model suggests that a 10% increase in RPA of Gordonia or a 10% decrease in RPA of Geobacillus will increase a NRS score by a factor of 1.76 or 2.16, respectively. These data support that bacterial microbiome (Gordonia and Geobacillus) is the dominant predictor of NRS score in this cohort (Table S4). Concordantly, Gordonia and Geobacillus RPA correlated with NRS score (Figure 2).
5 |. CONCLUSIONS
This is the first study to characterize the facial bacterial microbiome of twins. We took advantage of the relatively controlled nature of our study cohort and found that changes in the facial microbiome are associated with the changes in the NRS score (severity of rosacea) more so than previously identified demographic correlates. Specifically, we uncovered a positive and a negative association for Gordonia and Geobacillus with rosacea, respectively. Importantly, this was in the background of a largely unchanged microbiome landscape. This twin study can serve as a reference for future studies to confirm and pursue specific microbial associations with rosacea.
Supplementary Material
ACKNOWLEDGEMENTS
This study was supported in part by the Skin Diseases Research Center, NIH P30AR039750, start-up institutional funds to DLP and an award from the National Rosacea Society and Dermatology Foundation to DLP and MRG. We would like to acknowledge Mahmoud Ghannoum and Pranab Mukherjee for their critical and helpful suggestions.
Footnotes
CONFLICT OF INTEREST
The authors have no conflict of interests.
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article.
REFERENCES
- [1].Aldrich N, Gerstenblith M, Fu P, Tuttle MS, Varma P, Gotow E, Cooper KD, Mann M, Popkin DL, JAMA Dermatol. 2015, 151, 1213. [DOI] [PubMed] [Google Scholar]
- [2].Holmes AD, Steinhoff M, Exp. Dermatol 2017, 26, 659. [DOI] [PubMed] [Google Scholar]
- [3].Two AM, Wu W, Gallo RL, Hata TR, J. Am. Acad. Dermatol 2015, 72, 749. [DOI] [PubMed] [Google Scholar]
- [4].Hua TC, Chung PI, Chen YJ, Wu LC, Chen YD, Hwang CY, Chu SY, Chen CC, Lee DD, Chang YT, Liu HN, J. Am. Acad. Dermatol 2015, 73, 249. [DOI] [PubMed] [Google Scholar]
- [5].Rainer BM, Fischer AH, Luz D da Silva Felipe, Kang S, Chien AL, J. Am. Acad. Dermatol 2015, 73, 604. [DOI] [PubMed] [Google Scholar]
- [6].van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L, Cochrane Database Syst. Rev 2015, CD003262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, Program NCS, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA, Science 2009, 324, 1190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Si J, Lee S, Park JM, Sung J, Ko G, BMC Genom. 2015, 16, 992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Williams MR, Gallo RL, Curr. Allergy Asthma Rep 2015, 15, 65. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.